LogicBio Therapeutics is a biotech company focused on expanding the applications of genetic medicine through targeted delivery platforms. Their proprietary genome editing technology platform, GeneRide, uses homologous recombination to enable the site-specific integration of therapeutic transgenes without the need for nucleases or external promoters. The company is also working on developing a Next Generation Capsid platform for gene editing and gene therapies, which could be used for both internal development and potential collaborations. LogicBio is based in Lexington, Mass.
LogicBio Therapeutics, Inc.'s ticker is LOGC
The company's shares trade on the NASDAQ stock exchange
They are based in Lexington, Massachusetts
There are 11-50 employees working at LogicBio Therapeutics, Inc.
It is https://www.logicbio.com/
LogicBio Therapeutics, Inc. is in the Healthcare sector
LogicBio Therapeutics, Inc. is in the Biotechnology industry
The following five companies are LogicBio Therapeutics, Inc.'s industry peers: